Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial

PURPOSE: Provide 2-year efficacy, safety and treatment results comparing three anti-vascular endothelial growth factor (anti-VEGF) agents for center-involved diabetic macular edema (DME) utilizing a standardized follow-up and retreatment regimen. DESIGN: Randomized clinical trial. PARTICIPANTS: 660...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ophthalmology
Main Authors: Wells, John A., Glassman, Adam R., Ayala, Allison R., Jampol, Lee M., Bressler, Neil M., Bressler, Susan B., Brucker, Alexander J., Ferris, Frederick L., Hampton, G. Robert., Jhaveri, Chirag, Melia, Michele, Beck, Roy W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877252/
https://ncbi.nlm.nih.gov/pubmed/26935357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.02.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados